Drug Shortage Report for JAMP CEPHALEXIN SUSPENSION
| Report ID | 196744 |
| Drug Identification Number | 02528444 |
| Brand name | JAMP CEPHALEXIN SUSPENSION |
| Common or Proper name | Cephalexin For Oral Suspension USP |
| Company Name | JAMP PHARMA CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CEPHALEXIN |
| Strength(s) | 250MG |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | ORAL |
| Packaging size | 150 mL |
| ATC code | J01DB |
| ATC description | OTHER BETA-LACTAM ANTIBACTERIALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2023-06-20 |
| Estimated end date | 2024-02-15 |
| Actual end date | 2024-02-15 |
| Shortage status | Resolved |
| Updated date | 2024-02-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1310 RUE NOBEL BOUCHERVILLE, QUEBEC CANADA J4B 5H3 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v10 | 2024-02-27 | French | Compare |
| v9 | 2024-02-27 | English | Compare |
| v8 | 2023-12-18 | French | Compare |
| v7 | 2023-12-18 | English | Compare |
| v6 | 2023-10-18 | French | Compare |
| v5 | 2023-10-18 | English | Compare |
| v4 | 2023-08-03 | French | Compare |
| v3 | 2023-08-03 | English | Compare |
| v2 | 2023-06-27 | French | Compare |
| v1 | 2023-06-27 | English | Compare |
Showing 1 to 10 of 10